Medication info

Multi Blue 5 Weeks

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Zinc Sulfate Hydrate›4.39mg / 1mLCupric Sulfate Hydrate›1.57mg / 1mLManganese Sulfate Hydrate›0.308mg / 1mLChromic Chloride Hydrate›20.5μg / 1mLSelenious Acid›32.7μg / 1mL
Manufacturer / importer
Light Phamtech Co., Ltd.
Appearance
A colorless, odorless or light blue transparent solution contained in a colorless transparent vial injection
Packaging
25 vials/box [10 milliliters/vial x 25]
Approval status
Active

MFDS item code 201002166 · Notified 2010.03.19

Summary

Main use
Improvement of trace element (e.g., zinc and copper) supplementation during parenteral nutrition
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, and check plasma trace element levels to guide dosage adjustment. Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4㎎ per day Copper: 0.5∼1.5㎎ per day Manganese: 0.15∼0.8㎎ per day Chromium: 10∼15㎍ per day Selenium: 20∼40㎍ per day Patients with metabolically stable small intestinal fluid losses: Additional 12.2㎎/L (small intestinal fluid loss) or 17.1㎎/㎏ (stool output) Patients with acute catabolic illness: 4.5∼6㎎ per day Patients with metabolically stable small intestinal fluid losses: 20㎍ per day Deficiency due to long-term parenteral nutrition: 100㎍ per day may be used for 24∼31 days.
Child administration
Age 5 years or younger: Zinc 100㎍/kg body weight per day, copper 20㎍/kg body weight per day, manganese 2∼10㎍/kg body weight per day, chromium 0.14∼0.20㎍/kg body weight per day, selenium 3㎍/kg body weight per day

Ingredients

Manufacturer
Light Phamtech Co., Ltd.

Efficacy & effects

Improvement of trace element (e.g., zinc and copper) supplementation during parenteral nutrition

View approved original text

Administering trace elements including zinc, copper, manganese, selenium, and chromium during intravenous nutritional supplementation helps maintain nutritional balance and prevents essential mineral deficiencies in patients. These trace elements are essential for various enzyme reactions and metabolic processes in the body and play important roles in enhancing immune function and wound healing. Therefore, appropriate supplementation of trace elements during intravenous nutrition contributes to the overall recovery and health improvement of patients.

How it is given

Adult administration

Use as prescribed by a physician, and check plasma trace element levels to guide dosage adjustment. Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4㎎ per day Copper: 0.5∼1.5㎎ per day Manganese: 0.15∼0.8㎎ per day Chromium: 10∼15㎍ per day Selenium: 20∼40㎍ per day Patients with metabolically stable small intestinal fluid losses: Additional 12.2㎎/L (small intestinal fluid loss) or 17.1㎎/㎏ (stool output) Patients with acute catabolic illness: 4.5∼6㎎ per day Patients with metabolically stable small intestinal fluid losses: 20㎍ per day Deficiency due to long-term parenteral nutrition: 100㎍ per day may be used for 24∼31 days.

Child administration

Age 5 years or younger: Zinc 100㎍/kg body weight per day, copper 20㎍/kg body weight per day, manganese 2∼10㎍/kg body weight per day, chromium 0.14∼0.20㎍/kg body weight per day, selenium 3㎍/kg body weight per day

Precautions

This medication should not be administered to premature infants and newborns as it contains benzyl alcohol, which can cause fatal respiratory issues in these populations. Injecting this medication directly into the vein without dilution may cause phlebitis, so it must always be diluted before use. Additionally, since this medication is a hypoosmolar solution, it should only be used for mixed injections. If any toxic symptoms occur due to any of the components during administration, the use must be stopped immediately. The aluminum present in parenteral nutrition solutions may reach toxic levels if administered long-term to patients with impaired renal function, particularly in premature infants. Before administration, the physician should carefully assess the patient's condition and metabolic needs and regularly check blood trace element levels for dosage adjustment. In patients with renal failure, zinc elimination can be difficult, leading to accumulation in the body, so caution is necessary. Patients with bile duct obstruction may have difficulty excreting copper and manganese, leading to accumulation of these trace elements. Chromium is primarily excreted through the kidneys, and for diabetic patients, the use of antidiabetic medications should be checked. Selenium dosage adjustments are needed for patients with kidney and gastrointestinal dysfunction, and for patients receiving transfusions, the impacts of transfusions should be considered. For pregnant women or women of childbearing potential, the administration of this medication should be decided with caution, and should only be used if the benefits outweigh the risks. Excessive doses can cause toxic symptoms of trace elements such as zinc, copper, chromium, and selenium, so the prescribed dosage must be strictly adhered to. Particularly, acute toxic symptoms may occur with excessive zinc and symptoms such as dehydration, diarrhea, and hypotension may occur with excessive copper. This medication should not be used without a physician's prescription, and it is important to maintain aseptic conditions when adding to parenteral nutrition solutions. The solution should be inspected for discoloration or particles before administration. When storing, place the medication in a sealed container to protect it from air or moisture. It is recommended to maintain a storage temperature between 15 and 30 degrees Celsius (room temperature). Proper storage will help preserve the medication's effectiveness and safety.

Side effects

  • Shortness of breath
  • sweating
  • altered consciousness
  • blurred vision
  • tachycardia
  • hypothermia
  • hyperamylasemia
  • hypotension
  • pulmonary edema
  • diarrhea
Show 31 more
  • vomiting
  • jaundice
  • reduced urine output
  • weakness
  • behavioral changes
  • progressive wasting syndrome
  • photophobia
  • peripheral edema
  • nausea
  • ulcer
  • gastrointestinal disturbances
  • renal impairment
  • hepatic impairment
  • seizures
  • coma
  • alopecia
  • brittle nails
  • dermatitis
  • dental damage
  • irritability
  • depression
  • metallic taste
  • sweating
  • garlic odor during respiration
  • acute peripheral vascular collapse
  • vascular congestion
  • pulmonary bleeding
  • pulmonary congestion
  • pulmonary edema
  • gastric mucosal discoloration
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 15 and 30 degrees Celsius (room temperature) for best preservation of effectiveness and safety.

Appearance and packaging

Appearance

A colorless, odorless or light blue transparent solution contained in a colorless transparent vial injection

Package unit

25 vials/box [10 milliliters/vial x 25]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.